<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; chemotherapy</title>
	<atom:link href="http://oralcancernews.org/wp/tag/chemotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Tue, 27 Jul 2010 19:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Get moving: cancer survivors urged to exercise</title>
		<link>http://oralcancernews.org/wp/get-moving-cancer-survivors-urged-to-exercise/</link>
		<comments>http://oralcancernews.org/wp/get-moving-cancer-survivors-urged-to-exercise/#comments</comments>
		<pubDate>Tue, 29 Jun 2010 03:08:45 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[exercise]]></category>
		<category><![CDATA[lymphedema]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8977</guid>
		<description><![CDATA[
			
				
			
		
Source: apnews.myway.com
Author: Lauran Neergaard
New guidelines are urging survivors to exercise more, even &#8211; hard as it may sound &#8211; those who haven&#8217;t yet finished their treatment.
There&#8217;s growing evidence that physical activity improves quality of life and eases some cancer-related fatigue. More, it can help fend off a serious decline in physical function that can last [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/get-moving-cancer-survivors-urged-to-exercise/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral cancer doesn’t silence North Carolina man</title>
		<link>http://oralcancernews.org/wp/oral-cancer-doesn%e2%80%99t-silence-north-carolina-man/</link>
		<comments>http://oralcancernews.org/wp/oral-cancer-doesn%e2%80%99t-silence-north-carolina-man/#comments</comments>
		<pubDate>Thu, 03 Jun 2010 22:55:07 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[dip]]></category>
		<category><![CDATA[mouth cancer]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral surgery]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[tobacco]]></category>
		<category><![CDATA[ulcer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8785</guid>
		<description><![CDATA[
			
				
			
		
Source: The Cherokee Scout
Author: Lizz Harold
Marble – Switching out one form of tobacco for another, Rick Miller, 44, learned how to quit smoking and dipping the hard way.
Miller went to a doctor in March to see if an ulcer inside his mouth could be removed. He expected a round of antibiotics or oral surgery. He [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-cancer-doesn%e2%80%99t-silence-north-carolina-man/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Robotic tongue cancer surgery-Mayo Clinic</title>
		<link>http://oralcancernews.org/wp/robotic-tongue-cancer-surgery-mayo-clinic/</link>
		<comments>http://oralcancernews.org/wp/robotic-tongue-cancer-surgery-mayo-clinic/#comments</comments>
		<pubDate>Tue, 27 Apr 2010 02:14:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[robot]]></category>
		<category><![CDATA[robotic surgery]]></category>
		<category><![CDATA[surgery]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8524</guid>
		<description><![CDATA[
			
				
			
		

Fighting cancer is not easy. Chemotherapy, radiation and surgery can be very hard on your body. Take head and neck cancers, for example. These tumors are often hard to reach. Doctors have to cut through bones such as your jaw to reach them. Now, doctors at Mayo Clinic are using robots to access these cancers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/robotic-tongue-cancer-surgery-mayo-clinic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nuggets&#8217; coach again fighting cancer- this time of the throat</title>
		<link>http://oralcancernews.org/wp/nuggets-coach-again-fighting-cancer-this-time-of-the-throat/</link>
		<comments>http://oralcancernews.org/wp/nuggets-coach-again-fighting-cancer-this-time-of-the-throat/#comments</comments>
		<pubDate>Wed, 17 Feb 2010 18:19:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[Denver Nuggets]]></category>
		<category><![CDATA[George Karl]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[squamous cell head/neck cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7882</guid>
		<description><![CDATA[
			
				
			
		
Source: ESPN
Author: Ric Bucher
Denver Nuggets coach George Karl informed his team Tuesday afternoon that he is in another fight for his life with cancer.
Karl, who had been cancer-free since prostate surgery in July 2005, discovered a worrisome lump on his neck about six weeks ago. A biopsy determined that it was &#8220;very treatable and curable&#8221; [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/nuggets-coach-again-fighting-cancer-this-time-of-the-throat/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Induction chemotherapy before concomitant chemoradiotherapy improves outcomes of patients with locally advanced head and neck cancer</title>
		<link>http://oralcancernews.org/wp/induction-chemotherapy-before-concomitant-chemoradiotherapy-improves-outcomes-of-patients-with-locally-advanced-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/induction-chemotherapy-before-concomitant-chemoradiotherapy-improves-outcomes-of-patients-with-locally-advanced-head-and-neck-cancer/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 19:09:35 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head & neck cancer]]></category>
		<category><![CDATA[Platinol]]></category>
		<category><![CDATA[UK Head & Neck]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7853</guid>
		<description><![CDATA[
			
				
			
		
Source: CancerConsultants
Author: Staff

Researchers from Italy have reported that induction (neoadjuvant) chemotherapy prior to concomitant chemoradiotherapy improves outcomes of patients with locally advanced head and neck cancer. The details of this Phase II randomized trial were published early online in the Annals of Oncology on December 23, 2009.[1]
There have been several randomized and non-randomized clinical trials suggesting [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/induction-chemotherapy-before-concomitant-chemoradiotherapy-improves-outcomes-of-patients-with-locally-advanced-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA clears transoral robotic surgery – developed at Penn –for tumors of mouth, throat and voice box</title>
		<link>http://oralcancernews.org/wp/fda-clears-transoral-robotic-surgery-%e2%80%93-developed-at-penn-%e2%80%93for-tumors-of-mouth-throat-and-voice-box/</link>
		<comments>http://oralcancernews.org/wp/fda-clears-transoral-robotic-surgery-%e2%80%93-developed-at-penn-%e2%80%93for-tumors-of-mouth-throat-and-voice-box/#comments</comments>
		<pubDate>Sun, 20 Dec 2009 06:10:00 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[da Vinci Surgical System]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[robotic surgery]]></category>
		<category><![CDATA[speech]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[swallowing]]></category>
		<category><![CDATA[swallowing function]]></category>
		<category><![CDATA[TransOral Robotic Surgery]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7625</guid>
		<description><![CDATA[
			
				
			
		
Source: www.healthcanal.com
Author: staff
A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA). The da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, California) has been cleared for TransOral Otolaryngology surgical procedures to treat benign tumors and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-clears-transoral-robotic-surgery-%e2%80%93-developed-at-penn-%e2%80%93for-tumors-of-mouth-throat-and-voice-box/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Q&amp;A: treating larynx cancer with chemotherapy alone</title>
		<link>http://oralcancernews.org/wp/qa-treating-larynx-cancer-with-chemotherapy-alone/</link>
		<comments>http://oralcancernews.org/wp/qa-treating-larynx-cancer-with-chemotherapy-alone/#comments</comments>
		<pubDate>Thu, 03 Dec 2009 04:12:25 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[larynx]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[voicebox]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7504</guid>
		<description><![CDATA[
			
				
			
		
Source: www2.mdanderson.org/cancerwise
Author: Cancerwise Blogger
In certain cases, cancer of the larynx (voicebox) can be treated successfully with chemotherapy alone, according to a recent study at M. D. Anderson.
Chris Holsinger, M.D., assistant professor in the Department of Head and Neck Surgery, was co-author of the study, which is the first of its kind in the United States. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/qa-treating-larynx-cancer-with-chemotherapy-alone/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neck response to chemoradiotherapy</title>
		<link>http://oralcancernews.org/wp/neck-response-to-chemoradiotherapy/</link>
		<comments>http://oralcancernews.org/wp/neck-response-to-chemoradiotherapy/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 02:34:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[carboplatin]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[CT imaging]]></category>
		<category><![CDATA[lymph nodes]]></category>
		<category><![CDATA[neck dissection]]></category>
		<category><![CDATA[paclitaxel]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7385</guid>
		<description><![CDATA[
			
				
			
		
Source: Arch Otolaryngol Head Neck Surg. 2009;135(11):1133-1136
Author: Alexander Langerman, MD et al.
Complete Radiographic Response Correlates With Pathologic Complete Response in Locoregionally Advanced Head and Neck Cancer 
Objective:
The role of neck dissection following chemoradiotherapy (CRT) for locoregionally advanced head and neck cancer is an area of active debate. Patients who have a complete radiographic response may [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/neck-response-to-chemoradiotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Erbitux recognized by ASCO as a 2009 major cancer advance as first SCCHN  treatment to improve survival in 30 years</title>
		<link>http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/</link>
		<comments>http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 05:39:55 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[randomized trial]]></category>
		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7372</guid>
		<description><![CDATA[
			
				
			
		
Source: www.vwd.de
Author: press release
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with first-line recurrent and/or metastatic squamous [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/erbitux-recognized-by-asco-as-a-2009-major-cancer-advance-as-first-scchn-treatment-to-improve-survival-in-30-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemo treatments lengthen lives for head, neck cancer patients</title>
		<link>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/</link>
		<comments>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:29:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7315</guid>
		<description><![CDATA[
			
				
			
		
Source: www.privatemdlabs.com
Author:  Brendan Missett
Patients with head and neck cancer receiving a combined treatment of chemotherapy and radiation may live 2.1 years longer than those treated only with radiotherapy, new research suggests.
The study, published in the October 27 issue of The Lancet Oncology, separated 966 patients with advanced head and neck cancer into four treatment [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/chemo-treatments-lengthen-lives-for-head-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Weekly radiation of more than 10 gy improves local control in head and neck cancer patients</title>
		<link>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/</link>
		<comments>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 14:50:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[dose]]></category>
		<category><![CDATA[dysphagia]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7310</guid>
		<description><![CDATA[
			
				
			
		
Source: www.docguide.com
Author: John Otrompke
Patients with head and neck squamous cell carcinoma who receive an average weekly fractionated radiation dose of more than 10 gy experience significantly better local control at 2 years, unless they are receiving chemotherapy at the same time, according to a study presented here at the American Society of Therapeutic Radiology and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/weekly-radiation-of-more-than-10-gy-improves-local-control-in-head-and-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemoradiation confers long-term benefits in head and neck cancer</title>
		<link>http://oralcancernews.org/wp/chemoradiation-confers-long-term-benefits-in-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/chemoradiation-confers-long-term-benefits-in-head-and-neck-cancer/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 14:45:25 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[concomitant chemoradiation]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[toxicity]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7215</guid>
		<description><![CDATA[
			
				
			
		
Source: www.medscape.com
Author: Zosia Chustecka
In patients with head and neck cancer who do not undergo surgery, chemotherapy with nonplatinum agents given concurrently with radiotherapy offers clear benefits for recurrence and survival, say the authors of one of the largest and longest randomized trials carried out in this patient group.
Event-free survival in patients who received concomitant chemoradiation [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/chemoradiation-confers-long-term-benefits-in-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PMH finding may help some tonsil cancer patients avoid chemotherapy</title>
		<link>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/</link>
		<comments>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 19:27:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7178</guid>
		<description><![CDATA[
			
				
			
		
Source: www.sciencecodex.com
Author: staff
Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer (&#8220;tonsil cancer&#8221;) harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adding chemo helps head, neck cancer patients</title>
		<link>http://oralcancernews.org/wp/adding-chemo-helps-head-neck-cancer-patients/</link>
		<comments>http://oralcancernews.org/wp/adding-chemo-helps-head-neck-cancer-patients/#comments</comments>
		<pubDate>Thu, 29 Oct 2009 17:03:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[tumors]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7143</guid>
		<description><![CDATA[
			
				
			
		
Source: HealthDayNews
Author: Staff

TUESDAY, Oct. 27 (HealthDay News) &#8212; Combining chemotherapy with radiation treatment for patients with advanced head and neck cancer increases their event-free survival to 2.2 years from just one year with radiotherapy alone, finds a new study.
According to the study authors, &#8220;events&#8221; include cancer recurrence, new tumors or death.
British researchers looked at the 10-year outcomes [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/adding-chemo-helps-head-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Collaboration In The Quest To Contain Cancer</title>
		<link>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/</link>
		<comments>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/#comments</comments>
		<pubDate>Thu, 15 Oct 2009 19:44:10 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[chronic myelogenous leukemia]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Gleevec]]></category>
		<category><![CDATA[Imatinib]]></category>
		<category><![CDATA[infections]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6971</guid>
		<description><![CDATA[
			
				
			
		
Source: forbes.com
Author: Thomas Stossel
This year&#8217;s Lasker Foundation annual prize for medical breakthroughs&#8211;the American version of the Nobel Prize&#8211;recognizes a breakthrough cancer treatment that has revolutionized chemotherapy, a &#8220;targeted therapy for chronic myelogenous leukemia.&#8221; But more symbolic&#8211;and no doubt controversial&#8211;was to whom the prize was awarded: two academic scientists and a former drug company employee.
Ironically, the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
